dienogest has been researched along with Ovarian Diseases in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 12 (85.71) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Fujimoto, A; Honda, M; Isono, W; Matsuyama, R; Nishii, O; Saito, A; Tsuchiya, A; Tsuchiya, H | 1 |
Andou, M; Ebisawa, K; Hada, T; Kanno, K; Matsumoto, T; Nakajima, S; Ota, Y; Shirane, A; Yamanaka, A; Yanai, S | 1 |
Arena, A; Caprara, G; Del Forno, S; Mabrouk, M; Matteucci, C; Paradisi, R; Seracchioli, R; Zannoni, L | 1 |
Cho, S; Kim, SH; Lee, DY; Lee, SR; Seo, SK; Song, JY; Yi, KW | 1 |
Aylamazyan, E; Gzgzyan, A; Kogan, I; Muller, V; Niauri, D; Yarmolinskaya, M | 1 |
Choi, D; Kim, SE; Lee, DY; Seo, JW; Yoon, BK | 1 |
Arena, A; Del Forno, S; Giaquinto, I; Mabrouk, M; Mattioli, G; Paradisi, R; Seracchioli, R | 1 |
Angioni, S; Cela, V; Litta, P; Luisi, S; Malune, ME; Nappi, L; Pontis, A; Vignali, M | 1 |
Calagna, G; Colacurci, N; Cucinella, G; De Franciscis, P; Granese, R; Perino, A; Saitta, S; Svelato, A; Tonni, G | 1 |
Kurabayashi, T; Tamura, M; Tsuneki, I; Yanase, T | 1 |
Hayashi, A; Hayashi, M; Kyo, S; Ohmichi, M; Ono, YJ; Tanabe, A; Terai, Y; Yamashita, Y | 1 |
Adachi, K; Fujitani, M; Kimura, T; Kobayashi, E; Miyoshi, Y; Nakamura, K; Otake, A; Sasamoto, N; Sawada, K; Shioji, M; Takahashi, K; Tokuhira, A; Wakimoto, A; Yamamoto, Y; Yoshimura, A | 1 |
Kitawaki, J; Kusuki, I; Mita, S; Mizuguchi, K; Shimizu, Y; Suganuma, I; Xu, B; Yamanaka, K | 1 |
Fu, L; Hirata, T; Hirota, Y; Morimoto, C; Osuga, Y; Taketani, Y; Yano, T | 1 |
2 trial(s) available for dienogest and Ovarian Diseases
Article | Year |
---|---|
Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial.
Topics: Adult; Endometriosis; Endometrium; Female; Humans; Inflammation; Middle Aged; Nandrolone; Ovarian Diseases; Prospective Studies; Treatment Outcome; Young Adult | 2018 |
Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference?
Topics: Adolescent; Adult; Combined Modality Therapy; Contraceptives, Oral; Desogestrel; Drug Administration Schedule; Endometriosis; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Laparoscopy; Nandrolone; Norpregnenes; Ovarian Diseases; Secondary Prevention; Treatment Outcome; Young Adult | 2013 |
12 other study(ies) available for dienogest and Ovarian Diseases
Article | Year |
---|---|
Significant risk factors for malignant transformation of ovarian endometrioma during dienogest treatment: a case report and retrospective study.
Topics: Adenocarcinoma, Clear Cell; Adult; Age Factors; Cell Transformation, Neoplastic; Contraceptives, Oral, Hormonal; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Ovarian Diseases; Ovarian Neoplasms; Parity; Retrospective Studies; Risk Factors | 2019 |
Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis.
Topics: Endometriosis; Female; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Ovarian Diseases; Pain; Peritoneal Diseases; Recurrence; Retrospective Studies; Secondary Prevention; Treatment Outcome | 2017 |
Efficacy and Safety of Long-Term Use of Dienogest in Women With Ovarian Endometrioma.
Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Ovarian Diseases; Pain Measurement; Recurrence; Retrospective Studies; Treatment Outcome; Ultrasonography; Young Adult | 2018 |
Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF.
Topics: Adult; Endometriosis; Female; Fertilization in Vitro; Hormone Antagonists; Humans; Infertility, Female; Nandrolone; Ovarian Diseases; Ovulation Induction; Pregnancy; Pregnancy Rate; Prospective Studies; Treatment Outcome | 2017 |
Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery.
Topics: Adult; Contraceptives, Oral, Combined; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Nandrolone; Ovarian Diseases; Prospective Studies; Secondary Prevention; Young Adult | 2019 |
Dienogest or Norethindrone acetate for the treatment of ovarian endometriomas: Can we avoid surgery?
Topics: Adult; Contraceptives, Oral, Hormonal; Endometriosis; Female; Humans; Nandrolone; Norethindrone; Ovarian Diseases; Retrospective Studies | 2019 |
Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study.
Topics: Adult; Case-Control Studies; Contraceptives, Oral, Combined; Endometriosis; Ethinyl Estradiol; Female; Hormone Antagonists; Humans; Nandrolone; Ovarian Diseases; Pelvic Pain; Treatment Outcome; Young Adult | 2020 |
Relief of uterine bleeding by cyclic administration of dienogest for endometriosis.
Topics: Adult; Drug Administration Schedule; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Ovarian Diseases; Treatment Outcome; Uterine Hemorrhage; Young Adult | 2014 |
Decorin induced by progesterone plays a crucial role in suppressing endometriosis.
Topics: Adult; Cell Cycle; Cells, Cultured; Cross-Sectional Studies; Decorin; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Ovarian Diseases; Progesterone; Retrospective Studies; Transcriptional Activation; Young Adult | 2014 |
Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas.
Topics: Adult; Disease-Free Survival; Endometriosis; Female; Follow-Up Studies; Hormone Antagonists; Humans; Japan; Laparoscopy; Nandrolone; Outcome Assessment, Health Care; Ovarian Diseases; Pain Measurement; Pelvic Pain; Recurrence; Retrospective Studies | 2016 |
Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E₂ production in human endometriotic stromal cells in spheroid culture.
Topics: Adult; Aromatase; Aromatase Inhibitors; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; DNA; Dose-Response Relationship, Drug; Down-Regulation; Endometriosis; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Enzymologic; Humans; Immunohistochemistry; Nandrolone; NF-kappa B; Ovarian Diseases; Ovary; Real-Time Polymerase Chain Reaction; RNA, Messenger; Spheroids, Cellular; Stromal Cells; Young Adult | 2012 |
Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells.
Topics: Adult; Bromodeoxyuridine; Cell Cycle; Cell Proliferation; Cells, Cultured; Contraceptives, Oral; DNA; Drug Evaluation, Preclinical; Endometriosis; Female; G1 Phase; Humans; Nandrolone; Ovarian Diseases; Resting Phase, Cell Cycle; Stromal Cells | 2008 |